PHK
BIO icon

Point72 Hong Kong’s Bio-Rad Laboratories Class A BIO Stock Holding History

Point72 Hong Kong’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-286
Closed -$69.7K – 472
2025
Q1 		$69.7K Buy
+286
New +$86K ﹤0.01% 361
2024
Q4 		– Sell
-165
Closed -$55.2K – 408
2024
Q3 		$55.2K Buy
+165
New +$52.4K ﹤0.01% 372
2024
Q1 		– Sell
-22,517
Closed -$7.27M – 552
2023
Q4 		$7.27M Buy
+22,517
New +$7.06M 0.44% 65
2022
Q4 		– Sell
-5,800
Closed -$2.42M – 256
2022
Q3 		$2.42M Buy
5,800
+1,715
+42% +$855K 0.08% 306
2022
Q2 		$2.02M Buy
+4,085
New +$2.13M 0.07% 344
2022
Q1 		– Sell
-1,493
Closed -$1.13M – 1859
2021
Q4 		$1.13M Sell
1,493
-352
-19% -$263K 0.04% 524
2021
Q3 		$1.38M Buy
+1,845
New +$1.38M 0.04% 621
2021
Q2 		– Sell
-3,370
Closed -$1.93M – 1928
2021
Q1 		$1.93M Buy
+3,370
New +$2M 0.06% 413
2020
Q3 		– Sell
-1,334
Closed -$602K – 1205
2020
Q2 		$602K Buy
1,334
+1,205
+934% +$532K 0.07% 302
2020
Q1 		$45K Sell
129
-980
-88% -$360K 0.02% 369
2019
Q4 		$410K Buy
1,109
+311
+39% +$110K 0.1% 177
2019
Q3 		$266K Buy
798
+738
+1,230% +$241K 0.08% 228
2019
Q2 		$19K Buy
+60
New +$18K 0.01% 784
2018
Q2 		– Sell
-118
Closed -$30K – 903
2018
Q1 		$30K Buy
+118
New +$30K 0.02% 559
2017
Q4 		– Sell
-194
Closed -$43K – 851
2017
Q3 		$43K Buy
+194
New +$43.7K 0.03% 275
2017
Q1 		– Sell
-874
Closed -$159K – 743
2016
Q4 		$159K Buy
+874
New +$149K 0.16% 166
2015
Q4 		– Sell
-500
Closed -$67K – 495
2015
Q3 		$67K Buy
500
+100
+25% +$14.4K 0.1% 69
2015
Q2 		$60K Buy
+400
New +$57.2K 0.12% 112

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Point72 Hong Kong's BIO Position: Q2 2025 in Review

Point72 Hong Kong sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 286 shares — an estimated $69.7K sold.

Point72 Hong Kong first reported a position in BIO in Q2 2015 and held it in 18 quarters. The position peaked at $7.27M in Q4 2023. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Point72 Hong Kong reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 286 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $69.7K.
  • Point72 Hong Kong first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 18 quarters.
  • Point72 Hong Kong's Bio-Rad Laboratories Class A position peaked at $7.27M in Q4 2023.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.